Alcon (ALC) Non-Current Deferred Tax Liability (2009 - 2026)

Alcon (ALC) posted quarterly Non-Current Deferred Tax Liability of $944.0 million for Q1 2026, up 545.28% year-on-year from $146.3 million in Q1 2025, and little changed on a QoQ basis from $941.0 million in Q4 2025.

Alcon (ALC) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends

Alcon (ALC) has reported Non-Current Deferred Tax Liability for 11 consecutive years, with $944.0 million the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 545.28% year-over-year to $944.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $944.0 million (up 545.28% YoY) and the FY2025 annual result came in at $941.0 million, up 29.97% from the prior year.
  • Non-Current Deferred Tax Liability was little changed at $944.0 million in Q1 2026 per ALC's latest filing, from $941.0 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for ALC reached as high as $2.0 billion in Q4 2022 and fell as low as -$212.0 million in Q1 2025.
  • A 5-year average of $903.5 million and a median of $911.0 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2025 — Non-Current Deferred Tax Liability slumped 125.92% — and 2026, when it jumped 545.28%.
  • Year by year, Non-Current Deferred Tax Liability stood at $2.0 billion in 2022, then tumbled by 59.99% to $797.0 million in 2023, then fell by 9.16% to $724.0 million in 2024, then climbed by 29.97% to $941.0 million in 2025, then rose by 0.32% to $944.0 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $944.0 million, $941.0 million, and $911.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 944.00 Mn
Mar 31, 2026 944.00 Mn
Dec 31, 2025 941.00 Mn
Dec 31, 2025 941.00 Mn
Sep 30, 2025 911.00 Mn
Sep 30, 2025 911.00 Mn
Jun 30, 2025 857.00 Mn
Jun 30, 2025 857.00 Mn
Mar 24, 2025 -212.00 Mn
Mar 24, 2025 -212.00 Mn
Dec 31, 2024 724.00 Mn
Dec 31, 2024 724.00 Mn
Sep 30, 2024 785.00 Mn
Sep 30, 2024 785.00 Mn
Jun 30, 2024 792.00 Mn
Jun 30, 2024 792.00 Mn
Mar 31, 2024 818.00 Mn
Mar 31, 2024 818.00 Mn
Dec 31, 2023 797.00 Mn
Dec 31, 2023 797.00 Mn